Belluscura increases stake in TMT Acquisition to 90.81%, finalizing an all-share takeover deal worth £5.8M.

Belluscura has increased its stake in TMT Acquisition to 90.81% after its takeover bid became wholly unconditional. This follows an agreement of terms for an all-share offer last month. The London-listed medical device developer now owns 25 million shares of TMT Acquisition, a company specializing in technology, media, and telecom purchases. The takeover comes after Belluscura's announcement in October, agreeing to buy TMT Acquisition in an all-share deal valued at £5.8 million.

February 09, 2024
3 Articles